Education
About Us
Working with TipRanks
Follow Us
Laura A Williams Insider Profile
4 Followers
Laura A Williams, Director at Enliven Therapeutics, holds ― shares in Enliven Therapeutics (Ticker: ELVN), holds 402.58K shares in Ardelyx (Ticker: ARDX). Most recently, Laura A Williams ― shares of Enliven Therapeutics on ― for an estimated value of ―.
Laura A Williams Enliven Therapeutics (ELVN)Director
Enliven Therapeutics (ELVN)
Director
Ranked #99,805 out of 102,830 Corporate Insiders
Profitable Transactions
3 out of 10 Profitable Transactions
Average Return
-67.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Laura A Williams
Laura A Williams's Trading History
Enliven Therapeutics
―
Director
―
―
Ardelyx
May 22, 2025
CMO
Informative Sell
26.20K
$2.07M
List of latest transactions for each holding click on a transaction to see Laura A Williams's performance on stock
You May Also Like
Laura A Williams insider profile FAQ
What is the percentage of profitable transactions made by Laura A Williams?
The percentage of profitable transactions made by Laura A Williams is 30%.
What is the average return per transaction made by Laura A Williams?
The average return per transaction made by Laura A Williams is -67.70%.
What stocks does Laura A Williams hold?
Laura A Williams holds: ELVN, ARDX stocks.
What was Laura A Williams’s latest transaction?
Laura A Williams latest transaction was an Uninformative Buy of ―.
What was Laura A Williams's most profitable transaction?
Laura A Williams’s most profitable transaction was an Informative Sell of ARDX stock on June 7, 2024. The return on the trade was 42.90%.
What is Laura A Williams's role in Enliven Therapeutics?
Laura A Williams's role in Enliven Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.